6 months ago
BMRN
AnalystsMitchell S. KapoorMitchell S. Kapoor's Stock Forecasts
AnalystsMitchell S. Kapoor
Sectors:
Industries:
Analyst Ranking
Top 6%
#283 out of 5254 analysts
Average Return
+26.08%
Win Rate
67%58 out of 86
Risk vs Reward
Poor
Good
Mitchell S. Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +469.25% | $4.39 | $24.99 | 2025-08-13 - 2026-04-17 | Buy |
Oruka Therapeutics IncORKA | +351.93% | $15.25 | $68.92 | 2025-08-17 - 2026-04-17 | Buy |
Tyra Biosciences IncTYRA | +203.67% | $11.71 | $35.56 | 2025-08-21 - 2026-04-17 | Buy |
Kyverna Therapeutics IncKYTX | +167.65% | $3.71 | $9.93 | 2025-08-28 - 2026-04-17 | Buy |
Oruka Therapeutics IncORKA | +148.81% | $27.70 | $68.92 | 2025-10-26 - 2026-04-17 | Buy |
Mitchell S. Kapoor Analyst Color
Get additional color on Mitchell S. Kapoor's coverage of popular stocks
7 months ago
BMRN
Mitchell S. Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 5 | Sell | $5.00 | -76.80% | Reiterates | 2 days ago |
Legend Biotech CorpLEGN | 3 | Buy | $50.00 | +136.18% | Reiterates | 3 days ago |
Incyte CorpINCY | 6 | Buy | $135.00 | +38.01% | Reiterates | 3 days ago |
Oruka Therapeutics IncORKA | 3 | Buy | $70.00 | +1.57% | Maintains | 5 days ago |
Generate Biomedicines IncGENB | 1 | Buy | $16.00 | +28.51% | Initiates Coverage On | 5 days ago |
Alumis IncALMS | 4 | Buy | $25.00 | +0.04% | Maintains | 19 days ago |
Palisade Bio IncPALI | 1 | Buy | $7.00 | +191.67% | Initiates Coverage On | 23 days ago |
Ionis Pharmaceuticals IncIONS | 7 | Buy | $120.00 | +58.50% | Maintains | 24 days ago |
Avalo Therapeutics IncAVTX | 3 | Buy | $40.00 | +177.20% | Maintains | 24 days ago |
Evommune IncEVMN | 3 | Buy | $50.00 | +82.15% | Maintains | a month ago |
Cytomx Therapeutics IncCTMX | 2 | Buy | $17.00 | +252.70% | Maintains | a month ago |
Intellia Therapeutics IncNTLA | 7 | Buy | $30.00 | +100.67% | Maintains | 2 months ago |
Crescent Biopharma IncCBIO | 3 | Buy | $22.00 | +3.38% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 5 | Hold | $55.00 | +0.66% | Reiterates | 2 months ago |
Summit Therapeutics IncSMMT | 8 | Buy | $30.00 | +19.28% | Maintains | 2 months ago |
Tyra Biosciences IncTYRA | 2 | Buy | $45.00 | +26.55% | Maintains | 2 months ago |
Korro Bio IncKRRO | 2 | Buy | $20.00 | +38.99% | Upgrades | 3 months ago |
Neurogene IncNGNE | 4 | Buy | $70.00 | +151.35% | Reiterates | 3 months ago |
Lexeo Therapeutics IncLXEO | 4 | Buy | $10.00 | +44.72% | Maintains | 3 months ago |
Halozyme Therapeutics IncHALO | 5 | Buy | $90.00 | +29.89% | Reiterates | 4 months ago |
Lyell Immunopharma IncLYEL | 2 | Buy | $45.00 | +87.42% | Upgrades | 4 months ago |
Meiragtx Holdings PLCMGTX | 1 | Buy | $20.00 | +97.63% | Initiates Coverage On | 5 months ago |
Cartesian Therapeutics IncRNAC | 1 | Buy | $30.00 | +326.14% | Maintains | 5 months ago |
Kyverna Therapeutics IncKYTX | 2 | Buy | $20.00 | +101.41% | Maintains | 6 months ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $80.00 | +37.95% | Reiterates | 7 months ago |
Instil Bio IncTIL | 3 | Buy | $125.00 | +1,307.66% | Reiterates | 7 months ago |
Editas Medicine IncEDIT | 2 | Buy | $5.00 | +43.27% | Reiterates | 7 months ago |
Metagenomi Therapeutics IncMGX | 1 | Buy | $7.00 | +372.97% | Reiterates | 8 months ago |
Zura Bio LtdZURA | 1 | Hold | $2.00 | -65.58% | Maintains | 8 months ago |
Boundless Bio IncBOLD | 1 | Buy | $4.00 | +153.16% | Maintains | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.